AADI - Aadi Bioscience, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 169.84M
Enterprise value -1.06M
Trailing P/E 1.89
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)10.28
Price/book (mrq)1.07
Enterprise value/revenue -0.06
Enterprise value/EBITDA 0.02

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-47.53%
S&P500 52-week change 33.90%
52-week high 317.01
52-week low 36.80
50-day moving average 37.68
200-day moving average 311.18

Share statistics

Avg vol (3-month) 3137.39k
Avg vol (10-day) 395.91k
Shares outstanding 524.44M
Implied shares outstanding 6N/A
Float 815.43M
% held by insiders 111.61%
% held by institutions 164.13%
Shares short (14 May 2023) 41.29M
Short ratio (14 May 2023) 410.9
Short % of float (14 May 2023) 48.03%
Short % of shares outstanding (14 May 2023) 45.27%
Shares short (prior month 13 Apr 2023) 41.13M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 326 Aug 2021

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 0.00%
Operating margin (ttm)-330.04%

Management effectiveness

Return on assets (ttm)-24.75%
Return on equity (ttm)-45.73%

Income statement

Revenue (ttm)18.78M
Revenue per share (ttm)0.78
Quarterly revenue growth (yoy)154.30%
Gross profit (ttm)-18.78M
Net income avi to common (ttm)-61.88M
Diluted EPS (ttm)-2.57
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)151.17M
Total cash per share (mrq)6.19
Total debt (mrq)1.57M
Total debt/equity (mrq)1.07
Current ratio (mrq)9.29
Book value per share (mrq)5.97

Cash flow statement

Operating cash flow (ttm)-51.53M
Levered free cash flow (ttm)-33.14M